Results 191 to 200 of about 33,171 (260)

Acute Coronary Syndrome in Essential Thrombocythemia and Polycythemia Vera.

Heart Views
Kaddoura R, Ahmed D, Rudwan A, Elyas A, Yassin MA.   +4 more
europepmc   +1 more source

Basophilia and eosinophilia in polycythemia vera and essential thrombocythemia: clinical, genotype, and prognostic correlates. [PDF]

Ann Hematol
Faldu P, Yousuf M, Abdelmagid M, Dingli S, Begna K, Zepeda Mendoza CJ, Reichard KK, He R, Pardanani A, Gangat N, Tefferi A.   +10 more
europepmc   +1 more source

Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications [PDF]

Ivan Krečak, Danijela Leković, Isidora Arsenović, Andrija Bogdanović, Hrvoje Holik, Ivan Zekanović, Martina Morić Perić, Marko Lucijanić   +7 more
openalex   +1 more source

Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment [PDF]

, 2008
Colagrande, M, Di Ianni,M, Lapecorella, M, Lucchesi,A, Mariani, G., NAPOLITANO, Mariasanta, Tabilio, A   +6 more
core  

A comparative study of hematologic response to ropeginterferon alfa-2b in hydroxyurea-resistant or intolerant polycythemia vera: a real-world data-based analysis. [PDF]

Blood Res
Lee SE, Yoon SY, Kim SY, Bang SM, Lee I, Lee J, Hong J.   +6 more
europepmc   +1 more source

Relationship between amide ratio assessed by Fourier‐transform infrared spectroscopy: A biomarker candidate for polycythemia vera disease [PDF]

Zozan Güleken, Aynur Dağlar Aday, Ayşe Gül Bayrak, İpek Yönal Hindilerden, Meliha Nalçacı, J. Cebulski, Joanna Depciuch   +6 more
openalex   +1 more source

Real-world analysis of polycythemia vera treatment reveals nonadherence to NCCN guidelines in a large proportion of patients. [PDF]

Blood Neoplasia
Abu-Zeinah G, Hunter AM, Shatzel JJ, Yacoub A, Qin A, Chien HL, Mesa RA.   +6 more
europepmc   +1 more source

Large intramuscular hematoma due to acquired Factor VIII inhibitors in post Polycythemia Vera-Myelofibrosis. [PDF]

Clin Hematol Int
Prabhu RS, V S SR, S N R.
europepmc   +1 more source

Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design. [PDF]

Ann Hematol
De Stefano V, Passamonti F, Palandri F, Ramundo F, Rossi E, Betti S, Fagiolo L, Guglielmelli P, Abagnale DP, Pugliese N, Cattaneo D, Iurlo A, Branzanti F, Dedola A, Catellani H, Tieghi A, Basso M, Calistri E, Elli EM, Masselli E, Morsia E, Benevolo G, Breccia M, de Fazio V, Di Perna M, Marchetti M, Santoro M, Tafuri A, Castiglioni C, Rotella C, Siragusa S, Vannucchi AM, PROSPERO Study group.   +32 more
europepmc   +1 more source